Background. Treatment of contaminated surgical wounds is often complic
ated by the failure of local or systemic antibiotic treatment and prop
hylaxis. Locally administered liposome-encapsulated antimicrobials may
offer advantages over free antibiotics, including an increase in effi
cacy, ease of administration, and safety. The therapeutic advantages,
as well as the absorption and distribution of locally administered lip
osome-encapsulated antibiotics, were compared with those of locally ap
plied unencapsulated antibiotics in a contaminated wound model. Method
s. Anesthetized rats had a 1 cm incision over the midback that was ino
culated with 10(8) colony-forming units pseudomonas aeruginosa (group
1; n = 102) or left uninfected (group 2; n = 35). Before wound closure
, infected animals were treated with a local application of 0.3 ml sal
ine solution (untreated; n = 30), 5.5 mg tobramycin in 0.3 ml saline s
olution (free tobramycin; n = 30), or 0.3 ml liposome-encapsulated tob
ramycin (LET; n = 42). Animals were killed 24, 48, and 72 hours after
operation; serum and tissue tobramycin concentrations and tissue quant
itative cultures were studied. Liposomes were radiolabeled to examine
organ distribution. Results. The data show that LET produced sustained
local concentrations of antibiotic compared with free drug; sustained
concentration prolonged the antimicrobial effect despite a single dos
e of antibiotic. LET reduced tissue bacterial counts to a greater exte
nt and for a longer period of time than free tobramycin. The presence
of infection further reduced clearance of LET from the infected site.
Conclusions. The liposomal delivery of local antibiotics in this model
of surgical wound infection reduced the number of organisms more effe
ctively than locally applied free drug. Animals treated with LET had c
onsistently less than the 10(5) organisms per gm tissue considered cri
tical for invasive infection, suggesting that liposomal antibiotics ma
y be clinically useful in surgical wound prophylaxis.